Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2007
12/13/2007CA2653940A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864974A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient
12/12/2007EP1863933A2 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
12/12/2007EP1863772A1 Amide derivatives as ppar activators
12/12/2007EP1863768A1 Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester
12/12/2007EP1863767A1 Metabolites for nk-i antagonists for emesis
12/12/2007EP1863766A2 Certain substituted amides, method of making, and method of use thereof
12/12/2007EP1863757A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/12/2007EP1863751A1 Compound and organic light-emitting device
12/12/2007EP1730106A4 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
12/12/2007EP1503995B1 Method for producing substituted phenylsulfonyl urea
12/12/2007EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007EP1237859B1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
12/12/2007CN101087759A Anthracene derivative and organic electroluminescent element using the same
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101087528A Azine compounds for combating animal pests
12/12/2007CN101085710A Method for manufacturing alkyl and aryl ethers
12/12/2007CN100354285C Neutral metallic dendrimer complexes
12/12/2007CN100354271C Piperazine derivatives and process for the preparation thereof
12/12/2007CN100354260C Phthalamide derivative, agricultural or horticultural insecticide, and method of use thereof
12/11/2007US7307171 4'-Methyl-2,3'-bipyridyl; marine paints and surface treatments; repellents and selective inhibitors for aquatic and/or terrestrial crustacean pests.
12/11/2007US7307092 Compounds Capable of Activating Cholinergic Receptors
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007139096A1 Azo dye for anisotropic dye film
12/06/2007WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c
12/06/2007WO2007138048A1 Novel heterocyclic compounds
12/06/2007WO2007137738A1 Spirocyclic nitriles as protease inhibitors
12/06/2007US20070282148 Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins
12/06/2007US20070282110 Process for Preparing Diimine Compounds
12/06/2007US20070282109 Process for the Preparation of 17-0-Vinyl-Triflates as Intermediates
12/06/2007US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007US20070281977 antimalarial agent; 3-chloro-6-(hydroxymethyl)-2-methyl-5-[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]-4(1H )-pyridinone
12/06/2007US20070281954 Cyclohexyl-1,4-diamine compounds
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007US20070278719 Processing Method For Organic Crystal, Processing Device For Organic Crystal, And Observing Device For Organic Crystal
12/06/2007CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c
12/06/2007CA2653872A1 Novel heterocyclic compounds
12/06/2007CA2653662A1 Spirocyclic nitriles as protease inhibitors
12/05/2007EP1862860A1 Charge control agent and related technique
12/05/2007EP1862459A1 Novel heterocyclic compounds
12/05/2007EP1862458A2 Therapeutic agents useful for treating pain
12/05/2007EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007EP1861374A1 Carboxanilides as microbiocides
12/05/2007EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase.
12/05/2007EP1861370A1 2-pyridine derivatives as inhibitors of neutrophile elastase
12/05/2007EP1861369A1 Nicotinanilides method for production thereof and agents comprising the same for prevention of fungal pests
12/05/2007EP1861359A1 N-(n-sulfonylaminomethyl)cyclopropanecarboxamide derivatives useful for the treatment of pain
12/05/2007EP1861356A1 Imines as ion channel modulators
12/05/2007EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007EP1860941A1 Biphenyl-n-(4-pyridyl) methylsufonamides
12/05/2007EP1860940A1 Biphenyl-n- (4-pyridyl) methylsulfonamides
12/05/2007EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof
12/05/2007EP1368431B1 Pyridone dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles
12/05/2007EP1368318B1 Calcilytic compounds
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007CN101084206A N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
12/05/2007CN101084205A N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
12/05/2007CN101084192A Manufacture of vitamin B6
12/05/2007CN101081833A Preparation method of 2-amido-3-5-trifluoro picoline
12/05/2007CN101081832A Preparation method of 2-chlorin-5-trifluoro picoline
12/05/2007CN101081831A Preparation method of 2-chlorin-6-trifluoro picoline
12/05/2007CN100353581C Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352815C Phosphorescence compound and electro field light emitting device having the same
12/05/2007CN100352808C Heterocyclic diamide invertebrate pest control agents
12/05/2007CN100352804C 酰胺衍生物 Amide derivatives
12/04/2007US7304161 3,5-Dimethyl-benzoic acid N-tert-butyl-N'-(3-hydroxymethyl-5-methyl-2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-hydrazide; 3,5-Dimethyl-benzoic acid N-(1-tert-butyl-2-cyano-vinyl)-N'-(3-methoxy-2-methylbenzoyl)-hydrazide
12/04/2007US7304159 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins
12/04/2007US7304094 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304072 Spiro compounds
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304066 Pyridyl cyanoguanidine compounds
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2007137107A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/29/2007WO2007137029A1 Therapeutic fluoroethyl ureas
11/29/2007WO2007136574A2 Medical devices having polymeric regions based on vinyl ether block copolymers
11/29/2007WO2007136572A2 Antidiabetic bicyclic compounds
11/29/2007WO2007136125A1 Compound having heterocyclic ring and use thereof
11/29/2007WO2007136059A1 Composition for diagnosing amyloid-related disease
11/29/2007WO2007135562A2 Hydroxyphenyl derivatives and biological applications thereof
11/29/2007WO2007135463A1 Optical enantiomers of phenyramidol and process for chiral synthesis
11/29/2007WO2007135427A1 1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
11/29/2007WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007135111A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007WO2007114855A3 Glucagon receptor antagonists, preparation and therapeutic uses
11/29/2007WO2007113249A3 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
11/29/2007WO2007090749A3 Benzamide and heteroarene derivatives as cetp inhibitors
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 633